NFG
MDGL icon

Next Financial Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Next Financial Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-25
Closed -$2K – 2283
2019
Q4 		$2K Hold
25
– – ﹤0.01% 2183
2019
Q3 		$2K Hold
25
– – ﹤0.01% 2126
2019
Q2 		$3K Hold
25
– – ﹤0.01% 2024
2019
Q1 		$3K Hold
25
– – ﹤0.01% 1387
2018
Q4 		$3K Hold
25
– – ﹤0.01% 1682
2018
Q3 		$5K Buy
+25
New +$6.27K ﹤0.01% 1161

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Next Financial Group's MDGL Position: Q1 2020 in Review

Next Financial Group sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2020, closing a stake of 25 shares — an estimated $2K sold.

Next Financial Group first reported a position in MDGL in Q3 2018 and held it in 6 quarters. The position peaked at $5K in Q3 2018. 109 funds tracked by Wall St. Rank hold MDGL as of Q1 2020.

  • Next Financial Group reported no remaining Madrigal Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Next Financial Group sold 25 Madrigal Pharmaceuticals shares in Q1 2020, an estimated $2K.
  • Next Financial Group first reported a position in Madrigal Pharmaceuticals in Q3 2018 and held it in 6 quarters.
  • Next Financial Group's Madrigal Pharmaceuticals position peaked at $5K in Q3 2018.
  • 109 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2020.

Based on Next Financial Group's 13F filing for Q1 2020, filed 27 Apr 2020.